Quantitative Analysis of Interstitial Lung Disease via AI-Enhanced Chest CT in Patients with Idiopathic Inflammatory Myopathies: Correlation with Expert Visual Evaluation in 107 Cases - Scorecard - MDSpire
Advertisement
Quantitative Analysis of Interstitial Lung Disease via AI-Enhanced Chest CT in Patients with Idiopathic Inflammatory Myopathies: Correlation with Expert Visual Evaluation in 107 Cases
Clinical Scorecard: Quantitative Analysis of Interstitial Lung Disease via AI-Enhanced Chest CT in Patients with Idiopathic Inflammatory Myopathies: Correlation with Expert Visual Evaluation in 107 Cases
At a Glance
Category
Detail
Condition
Interstitial Lung Disease (ILD) in Idiopathic Inflammatory Myopathies (IIMs)
Key Mechanisms
AI-enhanced chest CT for objective assessment of ILD lesions
Target Population
Patients with confirmed idiopathic inflammatory myopathy and ILD
Care Setting
National reference center for neuromuscular diseases
Key Highlights
Up to 40% of IIM patients develop ILD, impacting prognosis significantly.
High-resolution CT (HRCT) is crucial for ILD detection and characterization.
AI algorithms provide objective assessment, reducing inter-observer variability.
Distinctive ILD patterns in IIM may challenge AI tool performance.
Study compares AI-based analysis with expert visual evaluation.
Guideline-Based Recommendations
Diagnosis
Confirm diagnosis of IIM according to 2017 ACR/EULAR criteria.
Utilize HRCT for identifying ILD-related lesions.
Management
Consider initiation or escalation of immunosuppressive or antifibrotic therapy based on HRCT findings.
Monitoring & Follow-up
Regular HRCT assessments to monitor ILD progression and treatment response.
Risks
Potential for inter- and intra-observer variability in visual HRCT assessment.
Patient & Prescribing Data
Patients with IIM and ILD, enrolled in a national registry.
AI-derived metrics may serve as imaging biomarkers for disease severity and outcomes.
Clinical Best Practices
Use AI-enhanced HRCT for more accurate quantification of ILD.
Ensure HRCT assessments are performed during clinically stable periods.
